ENGINEERED for the Scientific Race
Engineered for the biotherapeutic race
Overview
Our SCIENTIFIC INTELLIGENCE and research teams are industry experts, pioneers, and empowered freethinkers who are skilled at turning antibody research into clinical realities.
We deliver beyond full-scale antibody discovery and development services, driven by relentlessly robust:
- Outcomes, with diverse candidate pools and libraries
- Sequence and profile identification with a Function-First focus
- Unparalleled focus and identification of clinically relevant antibodies
- Platforms and technologies
- A whole new approach to AI for biotherapeutics with LENSai ™ Integrated Intelligence Technology
In silico, in parallel, in an instant
LENSai Integrated Intelligence Technology
From BioStrand (a subsidiary of IPA)
Services
Accelerate antibody discovery breakthroughs with an expanded network of people, platforms and technologies.
Target Analysis and Immunization
Proven strategies for choosing the right combination of immunogen immunization schedules and species to mitigate risk and ensure the best start…
Antibody Discovery and Characterization
Innovative platforms deliver high-affinity antibodies with unrivaled experience in sequencing and custom assay development…
Preclinical Services
We explore beyond the status quo to deliver preclinical antibody candidates and give you the edge — with single-source services…
LENSai Integrated Intelligence Technology
AI technology for drug discovery that analyzes biological knowledge from multiple domains and dimensions — concurrently…
Your ultimate source for protein production
Online Store
Extensive protein product catalog including leading global supplier of organoid growth factors: exclusive producer of WNT Surrogate-Fc fusion protein that is publicly cited in multiple peer review articles and a new diverse line of RSPO proteins.
Custom Programs
IPA custom rPEx® production: >7,500 batches with >95% purity* — renowned for its flexibility, reliability, and efficiency. Programs shipped in 8 weeks / 4 weeks for repeat batch production.
*Historical consolidated average
Trending topics
Lead the way with IPA.
Trending topics
We have the longest memory
Rabbit monoclonal antibodies with B Cell Select® with Function-First from IPA are unmatched for early identification of a high affinity, highly specific antibodies.
Bispecifics & IPA
Bring us your scaffold and we can do the rest. With years of experience using a variety of bi- and multi-specific modalities, IPA has end-to-end capabilities and throughput to ensure selection and development of the most relevant therapeutic candidates.
Wet lab + in silico
with LENSai
LENSai in silico applications for radically informed decisions are designed to lend great cost and time efficiencies, as part of the IPA antibody discovery portfolio of service.
1. ROOTS 2022: Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035; p.118